Changes in Gut Microbiota According to Disease Severity in a Lupus Mouse Model
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031006 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eui-Jeong Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gwangju Center, Korea Basic Science Institute, Gwangju 61751, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Basic Science Institute, National Research Foundation (NRF) funded by the Korean government (MSIT), Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT).
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease driven by immune dysregulation. This study investigated the relationship between gut microbiota and lupus severity using the MRL/lpr lupus mouse model. Mice were grouped based on total immunoglobulin (Ig)G, IgG2a levels, and urine albumin-to-creatinine ratio (ACR), allowing for the comparison of gut microbiota profiles across different disease severities. Interestingly, severe lupus mice exhibited significant reductions in Ruminiclostridium cellulolyticum, Lactobacillus johnsonii, and Kineothrix alysoides, while Clostridium saudiense, Pseudoflavonifractor phocaeensis, and Intestinimonas butyriciproducens were enriched. These microbial shifts correlated with elevated IgG, IgG2a, and ACR levels, indicating that changes in the gut microbiome may directly influence key immunological markers associated with lupus severity. The depletion of beneficial species and the enrichment of potentially pathogenic bacteria appear to contribute to immune activation and disease progression. This study suggests that gut microbiota dysbiosis plays a critical role in exacerbating lupus by modulating immune responses, reinforcing the link between microbial composition and lupus pathogenesis. Our findings provide the first evidence identifying these distinct gut microbial species as potential contributors to lupus severity, highlighting their role as key factors in disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gwangju Center, Korea Basic Science Institute, Gwangju 61751, Republic of Korea.
ORCID-Profile: Ji-Seon Ahn, Hea-Jong Chung
Förderung
- Korea Basic Science Institute
- National Research Foundation (NRF) funded by the Korean government (MSIT)
- Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT)
Zitieren
APA
Han, E. J., Ahn, J. S., Choi, Y. J., Kim, D. H., & Chung, H. J. (2025). Changes in Gut Microbiota According to Disease Severity in a Lupus Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031006
Vancouver
Han EJ, Ahn JS, Choi YJ, Kim DH, Chung HJ. Changes in Gut Microbiota According to Disease Severity in a Lupus Mouse Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031006
BibTeX
@article{Han2025,
author = {Han, Eui-Jeong and Ahn, Ji-Seon and Choi, Yu-Jin and Kim, Da-Hye and Chung, Hea-Jong},
title = {Changes in Gut Microbiota According to Disease Severity in a Lupus Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031006}
}
EUVIMED